Indian government to avail 120 million doses of COVID vaccine to bolster fight against C0VID-19

INDIA – Indian government has announced 120 million doses of COVID vaccine will be availed for use in the month of June to help mitigate the COVID situation in the country. This is an upscale from 79.4 million doses that were available in May for public inoculation in the Southern Asia country. According to the Indian government, 60.9 million doses will be made available by the central government to states for vaccination of healthcare and frontline workers and those above the age of 45 years, while 58.6 million doses will…

Read More

Pharmaceutical knowledge database DrugBank expands into new regions to compound global influence

CANADA – DrugBank, the world’s most complete and up-to-date pharmaceutical knowledge database, expands operations into Austria, Colombia, Indonesia, Italy, Malaysia, Thailand, and Turkey to better serve global partners. DrugBank augments human intelligence to improve the world’s health by offering a suite of products that enable healthcare companies to improve healthcare delivery through precision medicine or clinical software application, while uncovering insights by applying data science to drug discovery.  “With these new additions, our pharmaceutical knowledge base becomes even more accessible and comprehensive,” explains Mike Wilson, CEO of DrugBank.  Wilson continues…

Read More

FDA approves targeted therapy for KRAS lung cancer mutation

U.S – The Food and Drug Administration has approved a targeted therapy drug by AMGEN INC for non-small cell lung cancer with a specific mutation in a gene known as KRAS. The drug, sotorasib, which will be sold under the brand name Lumakras, shrank tumours with the KRAS mutation in around 36 percent of patients in clinical trials. This medication is designed to target a gene mutation known as KRAS G12C that occurs in about 13 percent of non-small cell lung cancers, or NSCLC, the most common type of lung…

Read More

UNICEF secures long-term supply of Sputnik V COVID-19 vaccine

RUSSIA – UNICEF has entered an agreement with Russian Direct Investment fund(RDIF), through its wholly owned subsidiary, Human Vaccine, for a supply of 220 million doses of Sputnik V vaccine. This agreement which is conditional on the product achieving an Emergency Use Listing from WHO, will see a total of 110 million people get immunized. UNICEF has also signed three other similar agreements with COVID-19 manufactures Serum Institute of India, Pfizer, and AstraZeneca in a bid to meet vaccine demand across the globe. Earlier, Moderna committed to supply 34 million…

Read More

Rand Pharmaceutical receives investment funding from FNB Business and Edge Growth to fuel enterprise expansion

SOUTH AFRICA – Rand Pharmaceutical Distributors(Rand Pharm) has received investment funds from FNB Business and Edge Growth through the Vumela fund. Edge Growth Principal and lead deal maker, Vuyiswa Nzimande, says the investment is targeted at supporting an acquisition that will boost capacity and create new partnerships that will result in sustained long-term growth. Rand Pharmaceutical Distributors earned the fund through their long history to invest in its people and local communities. The distributors have a track record in wholesale and distribution of pharmaceutical supplies. However, despite 20 years of…

Read More

Airtel Kenya Partners with MyDawa to enable users access services without additional data charges

KENYA – Airtel Kenya has partnered with e-pharmacy platform, MyDawa, to enable easy and fast access to medication.        This partnership is meant to enable users to access the MyDawa website or app without incurring additional data charges. Users will also be able to use Airtel Money services to pay for medicine, health, wealth, and personal care items. “We are happy to partner with Airtel, one of the top telecommunications service providers in the country, to ensure that their subscribers are able to access quality medical products in a convenient…

Read More

PharmEasy acquires Medlife to bolster healthcare service delivery in India

INDIA- Medlife has discontinued operations in India to join PharmEasy, one of India’s top online pharmacy and medical care platforms. This newly formed collaboration is expected to deliver innovative solutions toward delivering better experiences to consumers, delivery personnel and retail partners in India. The merger is expected to complement PharmEasy’s ever growing efforts to simplify healthcare and impact lives in India’s healthcare space. The transaction happens at a time when the e-pharmacy market is experiencing exponential growth, largely fuelled by restriction of movement and social distancing practices as per COVID-19 regulations. According…

Read More

CDC study shows mRNA COVID-19 vaccines are 94% effective in health care personnel

U.S – New C0VID-19 vaccines effectiveness study conducted by CDC shows that mRNA vaccines by Pfizer-Biotech and Moderna reduce ri According to the study, the FDA approved vaccines reduced the risk of contracting SARS-CoV-2 virus by 94% among health care workers who were fully vaccinated. This study is the largest one to date, covering a sample size distribution of 500,000 health care personnel across 25 U.S. states, provides concrete evidence that C0VID-19 vaccines are performing as expected in the real world. Compared to the earlier study by CDC  on health…

Read More

Biometrics and Health Information Pioneer LifeQ secures US$47m investment funding

SOUTH AFRICA – LifeQ, a provider of biometrics and health insights, has raised US$47 million in a Series A funding round led by One Bio Venture Studio, a Cape Town-based VC. With the funds received, LifeQ will enable hospitals and physicians to develop remote monitoring as well as the consumer-device monitoring. The biotech’s startup’s first remote patient monitoring solution will be channeled at both hospitals and general applications near the end of this year. The services offered will enable hospitals track vitals such as heart rate and breathing rate in wards beyond…

Read More

The Swiss confederation and WHO launch global BioHub for pathogen analysis, sharing and storage

SWITZERLAND – Switzerland has signed a memorandum of understanding with WHO to launch the first WHO BioHUB in Spiez, Switzerland. The facility, which is part of the WHO BioHub System announced in November 2020, will help in safe reception, sequencing, storage, and preparation of biological materials for distribution to other laboratories, so as to facilitate global preparedness against these pathogens. Pathogens are currently shared bilaterally between countries: A process that can be sluggish and deny the benefits to some. Member states will now be able to share biological material with…

Read More